Acepodia (ROCO:6976) Price-to-Tangible-Book : 2.35 (As of May. 27, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Acepodia Price-to-Tangible-Book?

As of today (2024-05-27), Acepodia's share price is NT$27.60. Acepodia's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was NT$11.77. Hence, Acepodia's Price to Tangible Book Ratio of today is 2.35.

The historical rank and industry rank for Acepodia's Price-to-Tangible-Book or its related term are showing as below:

ROCO:6976' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.43 Med: 3.02 Max: 3.02
Current: 2.43

During the past 4 years, Acepodia's highest Price to Tangible Book Ratio was 3.02. The lowest was 2.43. And the median was 3.02.

ROCO:6976's Price-to-Tangible-Book is ranked better than
56.18% of 1221 companies
in the Biotechnology industry
Industry Median: 2.8 vs ROCO:6976: 2.43

A closely related ratio is called PB Ratio. As of today, Acepodia's share price is NT$27.60. Acepodia's Book Value per Sharefor the quarter that ended in Jun. 2023 was NT$11.77. Hence, Acepodia's P/B Ratio of today is 2.35.

Acepodia Price-to-Tangible-Book Historical Data

The historical data trend for Acepodia's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia Price-to-Tangible-Book Chart

Acepodia Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

3.02

Acepodia Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial			-	-	-	-	3.02

Competitive Comparison of Acepodia's Price-to-Tangible-Book

For the Biotechnology subindustry, Acepodia's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acepodia's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acepodia's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Acepodia's Price-to-Tangible-Book falls into.

Acepodia Price-to-Tangible-Book Calculation

Acepodia's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	27.60	/	11.767
	=	2.35

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Acepodia Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Acepodia's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Acepodia (ROCO:6976) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175

Website

https://www.acepodia.com

Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia (ROCO:6976) Headlines

No Headlines